Citigroup Inc Atri Cure, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Citigroup Inc holds 34,445 shares of ATRC stock, worth $1.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,445

Previous 32,116 7.25%

Holding current value

$1.24 Million

Previous $731,000 32.01%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$20.34 - $29.5 $47,371 - $68,705	2,329 Added 7.25%	34,445 $965,000
Q2 2024 Aug 12, 2024	BUY	$19.86 - $29.09 $370,011 - $541,975	18,631 Added 138.16%	32,116 $731,000
Q1 2024 May 10, 2024	BUY	$28.21 - $37.78 $125,562 - $168,158	4,451 Added 49.27%	13,485 $410,000
Q4 2023 Feb 09, 2024	BUY	$32.99 - $43.25 $209,123 - $274,161	6,339 Added 235.21%	9,034 $322,000
Q3 2023 Nov 09, 2023	SELL	$41.12 - $57.73 $773,878 - $1.09 Million	-18,820 Reduced 87.47%	2,695 $118,000
Q2 2023 Aug 10, 2023	BUY	$40.44 - $49.6 $676,682 - $829,956	16,733 Added 349.92%	21,515 $1.06 Million
Q1 2023 May 11, 2023	BUY	$35.87 - $47.22 $45,985 - $60,536	1,282 Added 36.63%	4,782 $198,000
Q4 2022 Feb 09, 2023	SELL	$33.48 - $47.45 $42,151 - $59,739	-1,259 Reduced 26.46%	3,500 $155,000
Q3 2022 Nov 10, 2022	SELL	$38.25 - $52.62 $94,286 - $129,708	-2,465 Reduced 34.12%	4,759 $186,000
Q2 2022 Aug 10, 2022	BUY	$35.1 - $66.01 $53,352 - $100,335	1,520 Added 26.65%	7,224 $295,000
Q1 2022 May 12, 2022	SELL	$57.43 - $71.39 $584,350 - $726,393	-10,175 Reduced 64.08%	5,704 $374,000
Q4 2021 Feb 10, 2022	BUY	$63.4 - $87.14 $433,529 - $595,863	6,838 Added 75.63%	15,879 $1.1 Million
Q3 2021 Nov 10, 2021	BUY	$69.28 - $84.46 $626,360 - $763,602	9,041 New	9,041 $629,000

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.67B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account